Variant report
Variant | esv3337930 |
---|---|
Chromosome Location | chr3:179652358-179656756 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:179656028..179658566-chr3:179661317..179663384,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs547651561 | chr3:179652372-179652373 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs570533187 | chr3:179652394-179652395 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs191019203 | chr3:179652409-179652410 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs183046032 | chr3:179652472-179652473 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs369381745 | chr3:179652501-179652502 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs564771144 | chr3:179652559-179652560 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs570048660 | chr3:179652612-179652613 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs535894488 | chr3:179652638-179652639 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs555280729 | chr3:179652645-179652646 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs150019349 | chr3:179652683-179652684 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs7633488 | chr3:179652741-179652742 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs544302831 | chr3:179652768-179652769 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs571406641 | chr3:179652777-179652778 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs372847642 | chr3:179652778-179652779 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs59755960 | chr3:179652849-179652850 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs200944760 | chr3:179652924-179652925 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs546544309 | chr3:179652926-179652927 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs577749549 | chr3:179652947-179652948 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs543045105 | chr3:179653001-179653002 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs563445621 | chr3:179653024-179653025 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs144624454 | chr3:179653076-179653077 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs147840665 | chr3:179653204-179653205 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs141460108 | chr3:179653208-179653209 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs187387713 | chr3:179653209-179653210 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs527851730 | chr3:179653214-179653215 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs377052533 | chr3:179653259-179653260 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs142603914 | chr3:179653269-179653270 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs564429779 | chr3:179653273-179653274 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs533410116 | chr3:179653297-179653298 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs549909490 | chr3:179653303-179653304 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs190313210 | chr3:179653339-179653340 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs183160053 | chr3:179653340-179653341 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs535590770 | chr3:179653377-179653378 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs150992550 | chr3:179653378-179653379 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs533715862 | chr3:179653397-179653398 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs113553340 | chr3:179653403-179653404 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs28681233 | chr3:179653450-179653451 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs534791319 | chr3:179653462-179653463 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs112725683 | chr3:179653494-179653495 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs140771704 | chr3:179653507-179653508 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs577998425 | chr3:179653519-179653520 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs537305958 | chr3:179653539-179653540 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs556694194 | chr3:179653565-179653566 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs573547040 | chr3:179653612-179653613 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs187903407 | chr3:179653651-179653652 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs559002321 | chr3:179653658-179653659 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs192789614 | chr3:179653729-179653730 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs184318081 | chr3:179653763-179653764 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs564293264 | chr3:179653767-179653768 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs533465078 | chr3:179653777-179653778 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 17133270 | CNVD |
epilepsy | 18472482 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Parkinson disease | 21907011 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 21364760 | CNVD |
Anaplastic thyroid cancer | 17989125 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Ovarian cancer | 18208621 | CNVD |
Thyroid cancer | 17317825 | CNVD |
Thyroid cancer | 17989125 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Breast cancer | 21806811 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 16751803 | CNVD |
abnormal development | 18461090 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Autism | 19653912 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Prostate cancer | 17217626 | CNVD |
Adenocarcinoma | 19607727 | CNVD |
Squamous cell cancer | 19607727 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cancer | 20164920 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:179644400-179660000 | Weak transcription | Pancreas | Pancrea |
2 | chr3:179648400-179660000 | Weak transcription | Brain Dorsolateral Prefrontal Cortex | brain |
3 | chr3:179650600-179653000 | Enhancers | Brain Hippocampus Middle | brain |
4 | chr3:179650600-179653600 | Enhancers | Brain Substantia Nigra | brain |
5 | chr3:179651000-179652400 | Enhancers | Brain Inferior Temporal Lobe | brain |
6 | chr3:179651800-179653200 | Weak transcription | Fetal Brain Male | brain |
7 | chr3:179652000-179655200 | Weak transcription | Dnd41 | blood |
8 | chr3:179652000-179660200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
9 | chr3:179652400-179653800 | Weak transcription | Brain Inferior Temporal Lobe | brain |
10 | chr3:179653000-179659200 | Weak transcription | Brain Hippocampus Middle | brain |
11 | chr3:179653200-179653400 | Enhancers | Fetal Brain Male | brain |
12 | chr3:179653600-179660400 | Weak transcription | Brain Substantia Nigra | brain |
13 | chr3:179653800-179654000 | Genic enhancers | Brain Inferior Temporal Lobe | brain |
14 | chr3:179654000-179659800 | Weak transcription | Brain Inferior Temporal Lobe | brain |
15 | chr3:179655200-179655800 | ZNF genes & repeats | Dnd41 | blood |
16 | chr3:179655800-179656600 | Weak transcription | Dnd41 | blood |
17 | chr3:179656600-179664200 | Strong transcription | Dnd41 | blood |